Cytokinetics (CYTK) PT Raised to $95 at RBC Capital
Tweet Send to a Friend
(Updated - December 22, 2025 6:44 AM EST)
RBC Capital analyst Leonid Timashev raised the price target on Cytokinetics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
RBC Capital analyst Leonid Timashev raised the price target on Cytokinetics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
